Actually, it has been well-known that FGFR3 is one of the most frequently mutated genes in BC and is more frequent in lower tumor stage, with over 65% of NMIBC and about 15% of MIBC bearing an FGFR3 mutation (28, 29). This evidence concerns the gene FGFR3 and neoplasm.